Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Commercial Sponsor
Peter MacCallum Cancer Centre, Australian & New Zealand Urogenital and Prostate Cancer Trials Group Limited (ANZUP)
Scientific Title
A Randomised Non-comparative Phase II Trial of Biomarker-driven Intermittent Docetaxel Versus Standard-of-care (SOC) Docetaxel in Metastatic Castration-resistant Prostate Cancer (mCRPC)